1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Cirrhoses, Experimental Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P; Arroyo, V; Bosch-Marcé, M; Clària, J; Graziotto, A; Jiménez, W; Leivas, A; Rivera, F; Rodés, J | 1 |
| Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y | 1 |
| Arroyo, V; Asbert, M; Claria, J; Guarner, F; Jiménez, W; La Villa, G; López, C; Rivera, F; Rodés, J | 1 |
3 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ascites; Benzeneacetamides; Blood Pressure; Body Water; Diuresis; Heart Rate; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Vasopressins | 1995 |
Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Liver Cirrhosis, Experimental; Male; Osmolar Concentration; Rats; Rats, Wistar; Vasopressins; Water-Electrolyte Balance | 1994 |
Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Diuresis; Kidney; Liver Cirrhosis, Experimental; Male; Rats; Rats, Inbred Strains; Vasopressins; Water-Electrolyte Imbalance | 1989 |